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C-CAM (cell-CAM 105) is a transmembrane cell adhesion molecule, belonging to the immunoglobulin superfamily. It IS expressed m epitheha. 
vessel endotheha and leukocytes, and mediates mterceilular adhesion in rat hepatocytes by homophilic binding. Two major isoforms (C-CAM1 
and C-CAM2) that differ in their cytoplasmic domains occur A previous study demonstrated that C-CAM can bmd calmodulin in a Ca”-dependent 
manner. In this study we have expressed the cytoplasmtc domains of C-CAM1 and C-CAM2 m fusion proteins and measured calmodulin bmdmg 
by a gel overlay assay, using “SI-labelled calmodulin. Our results indtcate that the cytoplasmtc domains of both C-CAM1 and C-CAM2 can bmd 
calmoduhn. 
Adhesion: Calcium: Calmodulin: C-CAM: Immunoglobulm super-family 
1. INTRODUCTION 
C-CAM, a cell adhesion molecule belonging to the 
immunoglobulin superfamily, is expressed in several ep- 
ithelia, vessel endothelia, platelets and leukocytes [ 11. It 
was originally characterized in rat liver [3,3] and was 
found to mediate intercellular adhesion between hepa- 
tocytes by a Ca”‘-independent, homophilic binding 
mechanism [4]. In rat liver C-CAM invariably appears 
as two structurally related. highly glycosylated peptide 
chains with apparent molecular masses of 105 kDa and 
110 kDa [3,.5]. In recent studies both Culic et al. and our 
laboratory [6,7] showed that these two forms differ 
mainly in their cytoplasmic domains. The large form 
(C-CAMl) has a C-terminal, cytoplasmic domain of 71 
amino acids, while that of the small form (C-CAM2) is 
only 10 amino acids long. 
The sequences of liver C-CAM from different out- 
bred rat stocks differ in their extracellular, N-terminal 
portions, as well [7]. Accordingly, C-CAM in rat liver 
seems to appear in at least four different isoforms, C- 
CAM1 (a and b) and C-CAM2 (a and b) [7]. It is likely 
that even more isoforms in rat await discovery as the 
homologous molecules in man and mouse, known as 
biliary glycoprotein, exist in a large number of isoforms 
[7-91. Strikingly, all the mouse isoforms and all the 
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human transmembrane isoforms, have either of two cy- 
toplasmic domains. both of which are clearly homolo- 
gous to the two cytoplasmic domains found in the rat 
liver isoforms of C-CAM. 
The question arises, if the large number of isoforms 
are of importance for the function of C-CAM, and espe- 
cially if the two different cytoplasmic domains have 
different properties in the regulation of the molecule. It 
was previously demonstrated in our laboratory that rat 
liver C-CAM can bind calmodulin in a Ca”-dependent 
manner [IO]. Experiments with proteolytically derived 
peptides from purified C-CAM suggested that the calm- 
odulin binding was to the cytoplasmic domain [lo]. In 
the present study we have explored this binding further 
by using recombinant fusion proteins containing the 
cytoplasmic domains of C-CAM 1 or C-CAM2. The re- 
sults indicate that both of these domains can bind calm- 
odulin. 
2. MATERIALS AND METHODS 
2 1. Polyacrylumrde gel electrophores~s (SDS- PAGE) 
Proteins were electrophoresed under non-reducing or reducing (IO 
mM DTT wtth or wtthout boiling for 3 mm) conditions on 12% 
polyacrylamide gels in the presence of SDS. according to Laemmli 
[l 11. The gels were either stained with Coomasste brilliant blue, used 
for gel overlay assays with “51-labelled calmoduhn. or tmmunoblotted 
as previously described [3] using an antibody against the maltose 
binding protein (MBP) provtded by the manufacturer of the pMAL-c2 
vector system (New England Btolabs). 
2.2. Gel overlay assyl 
Calmodulin (bovine testis, Pharmacia) or RNase A (ribonuclease 
I ‘A’ from bovine pancreas. Pharmacia) were labelled wtth “‘I by the 
lactoperoxidase method and were used m a gel overlay assay, as 
described by Carhn et al. [12] Briefly, purtfied rat liver C-CAM [3], 
or bacterial lysates contammg fusion proteins. were subjected to SDS- 
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polyacrylamide gel electrophoresis, and the gels were fixed in 25% 
isopropanol and 10% acetic acid. After several washes m bmding 
buffer (0.2 M NaCl. 50 mM Tris-HCI, pH 7.6), containing either I mM 
CaClz or 1 mM EGTA. the gels were incubated with 1 mg/ml BSA in 
bmdmg buffer. They were then incubated with 10 pg of either 
[1’51]calmoduhn or [‘?]RNase A (- 1 x lO’cpm/pgprotem) in binding 
buffer with 1 mM CaClz or I mM EGTA, for 12 h Finally the gels 
were washed, dried and exposed to X-ray film. 
2.3. Oligonucleotide pruners 
The malE primer (5’-GGTCGTCAGACTGTCGATGAAGCC-3’) 
was purchased from New England Biolabs. The following oligonucle- 
otides, corresponding to sense (F) or antisense (B) sequences of the 
cytoplasmic domains of C-CAM, were synthesized by Scandinavian 
Gene Synthesis: 
F13 5’-TCCAGGAAGACTGGCG-3’ 
F14 5’-GCATACTTCCTTTATTCCAGG-3’ 
F 16 5’-TTCAATGCCCAGCAATCC-3’ 
B6 5’-TAAGTCGACCAGGACAGACAATGTCAC-3’ 
The underlined sequence in B6 is a Sal1 restriction site. 
2.4. Isolation of cDNA 
The cDNA used for the construction of the fusion proteins was 
produced either by RT-PCR (Reverse Transcriptase-Polymerase 
Chain Reaction) with rat liver poly (A’) RNA [7] as a template. or by 
PCR with a Lambda Zap (Stratagene) rat liver cDNA hbrary as a 
template. 0.5 pg of poly (A+) RNA was transcribed at 42°C for 60 mm 
with 25 U of AMV reverse transcriptase (Promega), 10 AM of B6 as 
a primer and 0.2 mM of each of the four dNTPs in a total reaction 
volume of 20 ~1. The reaction was stopped by heating for 5 mm at 
95”C, and the cDNA product (1 ml of reaction mixture) was amphfied 
by PCR. All PCR reactions were performed m a 50~1 reaction mixture 
containing 1 ~1 of template (RT-reaction mixture or cDNA library). 
10 mM Tris-HCI (pH 9.0) 50 mM KCI, 0.1% Triton X-100. 1.5 mM 
MgCI,, 200 mM of each of the dNTPs, 0.5 mM of each primer and 
2.5 U of Pfu polymerase (Stratagene). The primer combmations F13/ 
B6, F14/B6 and F16/B6 were used. All PCR reactions ran for 30 
seconds at 94”C, 30 s at 55°C and 1 mm at 72°C. 5 ~1 of the products 
were electrophoresed on a 0.8% agarose gel and stained with ethidium 
bromide. 
2.5. Productron and charactetxation of fusron protetns 
After cleavage of the pMAL-c2 vector (New England Biolabs) with 
XmnI and San, and cleavage of the purified cDNA fragments with 
Sall, the cDNA fragments were ligated mto the cloning box of the 
vector. Recombinant plasmids were amplified m the TBI host bacteria 
(New England Biolabs). Positive clones were selected by PCR screen- 
ing, with primer combmations appropriate for each cDNA Insert. The 
nucleotide sequences of the recombinant plasmids of each of the iso- 
lated clones were determined by the Taq DyeDeoxy Termmator Cycle 
Sequencing method (Applied Biosystem Inc.), using an Applied Bio- 
systems Model 373A DNA sequence analyser and the vector specific 
primer malE. Fusion protein expression was induced by addition of 
isopropyl-/?-o-thiogalactoside (IPTG). when bacterial suspensions had 
reached an optical density of A,,,, = 0.5. Two hours later bacterial 
lysates were prepared by repeated freeze-thawmg and lysozyme diges- 
tion. The fusion proteins in the lysates were analyzed by SDS-PAGE 
and immunoblottmg. 
3. RESULTS 
3.1. Construction und characterization off&ion proteins 
Three fusion proteins containing different portions of 
the cytoplasmic domains of C-CAM were produced 
(Fig. 1). Cl/71 contained the entire 71-amino acid cyto- 
plasmic domain of C-CAMl, Cl/26 contained the 26 
most C-terminal amino acids of the cytoplasmic domain 
of C-CAMl, and C2/10 contained the entire lo-amino 
acid cytoplasmic domain of C-CAM%. A fourth fusion 
protein, CO/22, served as a control. This fusion protein 
contained a stretch of 22 amino acids, of which the 7 
most N-terminal corresponded to 5 of the transmem- 
brane and 2 of the proximal cytoplasmic amino acids of 
C-CAM. The remaining 15 amino acids were com- 
pletely unrelated to any C-CAM sequence. The se- 
quences of all four fusion proteins were verified by nu- 
cleotide sequence determination of the recombinant 
plasmids. 
The four fusion proteins were successfully expressed 
by the TBI bacteria, as shown in Fig. 2A and B. They 
were identified by immunoblotting with an antibody 
against the maltose binding protein (Fig. 2B). Stainings 
of whole lysates revealed that the fusion proteins were 
overexpressed relative to the bacterial protein back- 
ground (Fig. 2A). The molecular masses of the wildtype 
fusion protein MBP/GAL and of the MBP part of the 
fusion proteins are 52 kDa and 42 kDa, respectively. 
The fusion proteins C1/26, C2/10 and CO/22 had the 
expected molecular masses (Fig. 2, lanes 2, 3 and 6). 
Fusion protein C1/71, however, appeared as two com- 
ponents (Fig. 2, lane 1). The largest component, which 
was the most abundant one, had the expected size. The 
smaller component did not disappear after chemical 
reduction and probably resulted from proteolytic degra- 
dation or alternate folding. The same two components 
appeared again when the construction and expression 
of Cl/71 was repeated in an independent experiment 
(data not shown). 
3.2. Calmodulin binding to f&on proteins 
The maltose binding protein binds specifically to am- 
ylose. However, all four recombinant fusion proteins 
C1/71, C1/26, C2/10 and CO/22 had lost this affinity and 
could accordingly not be purified by affinity-chroma- 
tography on amylose. Therefore, we used whole bacte- 
rial lysates for calmodulin binding experiments with the 
gel overlay assay. Purified liver C-CAM was included 
in the binding experiments as a positive control. As 
demonstrated in Fig. 2C, fusion proteins C1/71, Cl/26 
and C2/10, but not MBP/GAL or CO/22 bound calmod- 
ulin in the presence of Ca”. Calmodulin binding to any 
other bacterial protein was negligible. Independent con- 
structions of Cl/71 and C2/10 also bound calmodulin 
(data not shown). No calmodulin binding occurred in 
the presence of the calcium chelator EGTA (data not 
shown). The binding experiments shown in Fig. 2C were 
performed with non-reduced proteins. Binding also oc- 
curred after mild reduction (no boiling, data not 
shown). Reduction and boiling of the bacterial lysates 
caused heavy precipitation, which prevented binding 
experiments under these conditions. As a separate con- 
trol, gel overlay binding experiments were performed 
with [“‘I]RNase A. No binding was observed either in 
the presence or absence of Ca’+ (data not shown). 
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Extracellular TM Intracellular 
C-CAM 
C-CAM 1 (71aa) 
53 nucleotides deletion 
t t 
I I_-” 
/ 
/ 
r 
Frame shllt and a new stop codon 
C-CAM 2 (1 Oaa) 
B 
DNA produced by PCR for construction of fuwon proteins 
C-CAM 1 Fl3f06 1 t cm1 
F16/86 t , Cl/26 
C-CAM 2 Ft 3106 1 1 c2/10 
C 
C-CAM1 Clffl SR~GGGSDHRDLT~HKPST~HNLGPSDDSPN~ 
DDVSYSVLNFNAQQSKRPTSASSSPTEIVYSWKKK 71aa 
Cl/26 NAQQSKRPTSASSSPTEK 26aa 
C-CAM2 c2/10 SRKKGSGSF 1 Oaa 
Control co/22 AYFLYSRPAWIIWMFGVLLNRR 22aa 
Fig. 1. Construction of fusion proteins. (A) The hnear structure of C-CAM showing the extracellular. the transmembrane (TM) and the intracellular 
domams IS shown. The intracellular domams of C-CAM 1 and C-CAM2 contam 71 and 10 amino acrds. respectively. (B) DNA species corresponding 
to different parts of the cytoplasmrc domains of C-CAM were made by PCR with the following primer combinations* Fi 3186, the entire cytopiasmic 
domain of C-CAM1 = C1171. F16/B6, the distal 26 C-termmal amino actds of the cytoplasmic domain of C-CAM1 = C1126, F131B6. the entrre 
cytoplasmic domain of C-CAM:! = C2/10: F14iB6, whtch resulted m DNA unrelated to C-CAM was used to construct fuston protem CO/22 (see 
Fig. 1C) After cleavage wtth Sal1 and ligatton into the pMAL-c2 vector, bacterial translatton ytelded fusion proteins Cl/71 (C-CAM1 amino acid 
residues 449-519), Cl/26 (C-CAM I ammo acid residues 494519) C2/10 (C-CAM2 ammo acid residues 449458), and CO/22 respecttvely. (C) The 
amino actd sequences (single letter code) deduced from the four DNA spectes CU71, C1126, C2110 and CO/22, respectively. 
4. DISCUSSION 
In the present study we have demonstrated that fu- 
sion proteins containing sequences corresponding to the 
cytoplasmic domains of C-CAM1 and C-CAM2 can 
bind calmodulin, The binding was strictly Ca”-depend- 
ent and quite specific. Very little calmoduhn binding 
occurred to any other bacterial proteins, and radiola- 
belled RNase A did not bind. Since neither the wildtype 
fusion protein MBPIGAL nor the control fusion protein 
CO/22 exhibited any significant calmodulin binding, C- 
CAM-specific sequences seem to be responsible for the 
observed binding. These results strengthen the conclu- 
sions of our previous study of caimodulin binding to 
proteolytically derived peptides of liver C-CAN [lo], 
and suggest that both the large and the small cytoplas- 
mic domains of C-CAM contain calmodulin binding 
motifs. 
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Fig. 2. SDS-PAGE and calm~ulin binding of fusion proteins. Total 
bacterial lysates were subjected to SDS-PAGE under non-reducmg 
conditrons. The gels were stained with Coomassie blue (A). im- 
munoblotted with an antibody against the maltose bindmg protein 
(B), or subjected to gel overtay assay with ‘~I-labeil~ calmoduhn m 
the presence of CaCl, (C). Lane 1. bacteria expressing C1171; lane 2, 
bacteria expressing C1126; lane 3, bacteria expressing C2110; iane 4, 
bacteria expressing the wtldtype MBPlGAL protein: lane 5, bacteria 
expressing CO/Q lane 6, purified rat liver C-CAM. Molecular weight 
marker proteins are shown ta the left m (A). Pure C-CAM stains 
poorly with Coomassie blue and 1s therefore not detected in (A), 
lane 6. 
4 5 6 
The sequence of the six membrane-proximal amino 
acids is identical in C-CAM1 and GCAM2, suggesting 
that this sequence is essential for calmodulin binding. 
However, since ealmodulin bound also to the fusion 
protein Clf26, that contains the 26 C-terminal distal 
amino acids of C-CAM 1, a second binding site is sug- 
gested in the cytoplasmic domain of C-CAM 1. 
~a~modulin is known to bind to a variety of intracel- 
lular proteins. No consensus binding sequence has been 
found. but in all of the characterized calmodulin bind- 
ing sites both positively charged and hydrophobic 
ammo acids are abundant 113,141. Many of these se- 
quences probably form basic amphiphilic alpha helices. 
The putative calmodulin binding sequences in the cyto- 
plasmic domains of C-CAM1 and C-CAM2 fulfil some 
of these requirements in that they contain both posi- 
tively charged and hydrophobic amino acids. 
Calcium-regulated calmodulin binding influences the 
activities of several different enzymes, membrane trans- 
port proteins and cytoskeletal proteins [13,15-171. It is 
thus tempting to speculate that the calcium-dependent 
binding of calmodulin to the cytoplasmic domains of 
C-CAM could control the fu~lctional activity of this 
transmembrane protein. Indeed, it has recently been 
demonstrated that the cytoplasmic domains of C-CAM 
can have a regulatory role in that C-CAM1 with the 
large cytoplasmic domain, but not C-CAM2 with the 
small cytoplasmic domain, conferred intercehular adhe- 
sion activity to insect Sf9 cells [18]. Furthermore, the 
cytoplasmic domains of C-CAM can be phosphorylated 
on both serine and tyrosine residues [3,19], several of 
which are contained in the putative calmodulin binding 
regions. Phosphorylation of these residues might alter 
the binding of calmodulin, with possible consequences 
for the extracellular function of C-CAM. Conversely, 
changes in the extracellular, C-CAM-mediated adhe- 
sion status of the celf could regulate calmodulin binding 
to C-CAM, thereby affecting the activities of other cyto- 
plasmic, calmodulin-regulated proteins. 
In conclusion, our results indicate that the cytoplas- 
mic domains of both C-CAM1 and C-CAM2 can bind 
calmodulin in a calcium-dependent manner. The eluci- 
dation of the location, structure and regulation of the 
binding sites, as well as of the possible effect of changes 
in calmodulin binding on the function of C-CAM. re- 
mains for future studies. 
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